Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Wenzhu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1966-1151; OpenAlex author ID A5101730763. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 8

  1. Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in … Co-author DOI 10.1016/j.canlet.2022.215859↗
  2. FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-017-0052-1↗
  3. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.13351↗
  4. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Co-author DOI 10.1016/j.canlet.2017.09.019↗
  5. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.13202↗
  6. The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1. Co-author DOI 10.1007/s13277-015-4234-0↗
  7. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-rela… Co-author DOI 10.1016/j.canlet.2015.12.010↗
  8. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. Co-author DOI 10.1186/s12967-015-0442-z↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shangyou Zheng · 8 shared papers, 2015–2022 · strength 0.52
  2. Xiaohui Zhao · 7 shared papers, 2015–2022 · strength 0.46
  3. Yimin Liu · 6 shared papers, 2015–2022 · strength 0.40
  4. Huilin Ye · 6 shared papers, 2015–2022 · strength 0.40
  5. Zhiqiang Fu · 6 shared papers, 2015–2018 · strength 0.35
  6. Quanbo Zhou · 5 shared papers, 2015–2022 · strength 0.34
  7. Zhihua Li · 5 shared papers, 2015–2022 · strength 0.33
  8. Yingxue Wang · 4 shared papers, 2016–2022 · strength 0.29
  9. Wenchao Gao · 4 shared papers, 2015–2022 · strength 0.26
  10. Huimou Chen · 4 shared papers, 2015–2022 · strength 0.26
  11. Yuming Luo · 3 shared papers, 2016–2022 · strength 0.24
  12. Rufu Chen · 4 shared papers, 2016–2018 · strength 0.23
  13. Rufu Chen · 3 shared papers, 2015–2022 · strength 0.22
  14. Yanhui Jiang · 3 shared papers, 2016–2018 · strength 0.17
  15. Langping Tan · 2 shared papers, 2016–2022 · strength 0.17
  16. Lusheng Wei · 2 shared papers, 2017–2018 · strength 0.13
  17. Zhihua Li · 2 shared papers, 2017–2018 · strength 0.13
  18. Changhao Chen · 2 shared papers, 2017 · strength 0.12
  19. Guolin Li · 2 shared papers, 2016–2018 · strength 0.12
  20. Chen Rufu · 1 shared paper, 2018 · strength 0.07
  21. Yue Zhao · 1 shared paper, 2017 · strength 0.06
  22. Yu Zhou · 1 shared paper, 2015 · strength 0.04
  23. Jin-Long Zeng · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.